Related references
Note: Only part of the references are listed.Anticancer, Azonafide-Inspired Fluorescent Ligands and Their Rhenium(I) Complexes for Cellular Imaging
Emily E. Langdon-Jones et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes
Kevin M. Knopf et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
New cyrhetrenyl and ferrocenyl sulfonamides: Synthesis, characterization, X-ray crystallography, theoretical study and anti-Mycobacterium tuberculosis activity
Cristobal Quintana et al.
POLYHEDRON (2017)
Cyclometalated Iridium(III) and Rhodium(III) Complexes Containing Naphthyridine Ligands: Synthesis, Characterization and Biological Studies
Marion Graf et al.
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE (2017)
Synthesis, Structural Characterization and Biological Evaluation of Rhenium(I) Tricarbonyl Complexes with β-Carboline Ligands.
Ivan Maisuls et al.
CHEMISTRYSELECT (2017)
Recent development of luminescent rhenium(I) tricarbonyl polypyridine complexes as cellular imaging reagents, anticancer drugs, and antibacterial agents
Lawrence Cho-Cheung Lee et al.
DALTON TRANSACTIONS (2017)
Benzannulated Re(I)-NHC complexes: synthesis, photophysical properties and antimicrobial activity
Daniel Siegmund et al.
DALTON TRANSACTIONS (2017)
Highly Potent Antibacterial Organometallic Peptide Conjugates
Bauke Albada et al.
ACCOUNTS OF CHEMICAL RESEARCH (2017)
Discovery of novel 2-(4-aryl-2-methylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors
Toshiyuki Kohara et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery of novel 2-(3-phenylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors
Yoshihiro Usui et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase Phosphorylation
Peter V. Simpson et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Asymmetric rhenium tricarbonyl complexes show superior luminescence properties in live cell imaging
Lukasz J. Raszeja et al.
CHEMICAL COMMUNICATIONS (2017)
Synthesis, In vitro and Docking Studies of New Flavone Ethers as α-Glucosidase Inhibitors
Syahrul Imran et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2016)
GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation
Kalpana Gupta et al.
CANCER RESEARCH (2016)
A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity
Sophia Hu et al.
MOLECULAR CANCER THERAPEUTICS (2016)
GABABR/GSK-3β/NF-κB signaling pathway regulates the proliferation of colorectal cancer cells
Qing Shu et al.
CANCER MEDICINE (2016)
Synthesis, reactivity, electrochemical behaviour, and molecular structure of crown ether cyrhetrene complexes
Fernando Godoy et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2015)
An organometallic structure-activity relationship study reveals the essential role of a Re(CO)(3) moiety in the activity against gram-positive pathogens including MRSA
Malay Patra et al.
CHEMICAL SCIENCE (2015)
Underestimated Potential of Organometallic Rhenium Complexes as Anticancer Agents
Anna Leonidova et al.
ACS CHEMICAL BIOLOGY (2014)
Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth
Yvette M. Carter et al.
CANCER BIOLOGY & THERAPY (2014)
Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1
S. Shin et al.
ONCOGENE (2014)
Insights into the Interactions between Maleimide Derivates and GSK3β Combining Molecular Docking and QSAR
Luisa Quesada-Romero et al.
PLOS ONE (2014)
Glycogen Synthase Kinase 3 Protein Kinase Activity Is Frequently Elevated in Human Non-Small Cell Lung Carcinoma and Supports Tumour Cell Proliferation
Emma E. Vincent et al.
PLOS ONE (2014)
GSK-3 as potential target for therapeutic irvention in cancer
James A. McCubrey et al.
ONCOTARGET (2014)
Analysis of the Mechanism of Action of Potent Antibacterial Hetero-tri-organometallic Compounds: A Structurally New Class of Antibiotics
Michaela Wenzel et al.
ACS CHEMICAL BIOLOGY (2013)
The potential of organometallic complexes in medicinal chemistry
Gilles Gasser et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2012)
Challenges and Opportunities in the Development of Organometallic Anticancer Drugs
Christian G. Hartinger et al.
ORGANOMETALLICS (2012)
Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonists
Sahar Mahmoud Abou-Seri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3 beta
G. Ekin Atilla-Gokcumen et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)
Organometallic Anticancer Compounds
Gilles Gasser et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis and antimalarial activities of rhenium bioorganometallics based on the 4-aminoquinoline structure
Rodrigo Arancibia et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Efficient microwave combinatorial synthesis of novel indolic arylpiperazine derivatives as serotoninergic ligands
Francesco Frecentese et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity
F. Benedetti et al.
GENES BRAIN AND BEHAVIOR (2010)
Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia
Vamsidhar Akurathi et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis
Rodrigo Machado-Vieira et al.
BIPOLAR DISORDERS (2009)
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
V. Bilim et al.
BRITISH JOURNAL OF CANCER (2009)
Potential Therapeutic Effect of Glycogen Synthase Kinase 3β Inhibition against Human Glioblastoma
Katsuyoshi Miyashita et al.
CLINICAL CANCER RESEARCH (2009)
Photoregulated Release of Caged Anticancer Drugs from Gold Nanoparticles
Sarit S. Agasti et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Association of GSK3B with Alzheimer disease and frontotemporal dementia
Barbara A. J. Schaffer et al.
ARCHIVES OF NEUROLOGY (2008)
Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors
Angela G. Koryakova et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Extremely Tight Binding of a Ruthenium Complex to Glycogen Synthase Kinase 3
G. Ekin Atilla-Gokcumen et al.
CHEMBIOCHEM (2008)
Glycogen synthase kinase-3 beta; A new target in pancreatic cancer?
G. Garcea et al.
CURRENT CANCER DRUG TARGETS (2007)
Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells
Muthusamy Kunnimalaiyaan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Ruthenium half-sandwich complexes as protein kinase inhibitors:: An N-succinimidyl ester for rapid derivatizations of the cyclopentadienyl moiety
Howard Bregman et al.
ORGANIC LETTERS (2006)
Aberrant nuclear accumulation of glycogen synthase kinase-3β in human pancreatic cancer:: Association with kinase activity and tumor dedifferentiation
Andrei V. Ougolkov et al.
CLINICAL CANCER RESEARCH (2006)
Organometallic compounds with biological activity: A very selective and highly potent cellular inhibitor for glycogen synthase kinase 3
G. Ekin Atilla-Gokcumen et al.
CHEMBIOCHEM (2006)
Glucosamine conjugates of tricarbonylcyclopentadienyl rhenium(I) and technetium(I) cores
Cara L. Ferreira et al.
INORGANIC CHEMISTRY (2006)
Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells
Qi Cao et al.
CELL RESEARCH (2006)
Deregulated GSK3β activity in colorectal cancer:: Its association with tumor cell survival and proliferation
A Shakoori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Synthesis, characterization and antiproliferative behavior of tricarbonyl complexes of rhenium(I) with some 6-amino-5-nitrosouracil derivatives:: Crystal structure of fac-[ReCl(CO)3(DANU-N5,O4)] (DANU=6-amino-1, 3-dimethyl-5-nitro souracil)
NA Illán-Cabeza et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2005)
Glycogen synthase kinase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cancer cells
AV Ougolkov et al.
CANCER RESEARCH (2005)
Selective estrogen-receptor modulators (SERMs) in the cyclopentadienylrhenium tricarbonyl series:: Synthesis and biological behaviour
S Top et al.
CHEMBIOCHEM (2004)
Preparation and characterization of poly(amidoamine) dendrimers functionalized with a rhenium carbonyl complex and PEG as new IR probes for carbonyl metallo immunoassay
JM Heldt et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2004)
Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth
M Mazor et al.
ONCOGENE (2004)
Structural characterization of the GSK-3β active site using selective and non-selective ATP-mimetic inhibitors
JA Bertrand et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer
CPS Potter et al.
BRITISH JOURNAL OF CANCER (2003)
Modern synthetic methods for copper-mediated C(aryl)-O, C(aryl)-N, and C(aryl)-S bond formation
SV Ley et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
A Martinez et al.
MEDICINAL RESEARCH REVIEWS (2002)